Brought to you by 
Third time is a charm for Atossa Genetics: company finally completes IPO
28 Jan 2014
Executive Summary
Two years after its first filing attempt (and two subsequent withdrawals), molecular diagnostics start-up Atossa Genetics Inc. has finally gone public netting $3.7mm by selling 800k shares at $5 apiece.
Deal Industry
- Biotechnology
- In Vitro Diagnostics
- Services
-
Medical Devices
- Diagnostic Equipment & Supplies
-
In Vitro Diagnostics
- Cytology
- Molecular Diagnostics & Genetic Testing
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Third time is a charm for Atossa Genetics: company finally completes IPO
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice